PALISADE CAPITAL MANAGEMENT, LP

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1009006 FORT LEE, NJ

Position in LGND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,097,816

New position

Shares Held

20,525

first reported quarter

Ownership

0.102%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 55.71254567600488.ToString("F0")% Shared 44.28745432399513.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $15,866,285 across 3 Biotechnology names. LGND ranks #3 (25.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	40,563	$6,855,958
2	HRTX	Heron Therapeutics, Inc. /De/	6,140,639	$4,912,511
3	LGND	Ligand Pharmaceuticals Inc This page	20,525	$4,097,816

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,097,816	20,525	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.